Search Results 401-410 of 18476 for Prednisone

1. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Participation eligibility · Corticosteroids. Active disease despite a history of at least an induction regimen of a dose equivalent to oral prednisone 30 mg ...

2. Clinical trials - Oncology (Medical)

   ... prednisone given in 21-day treatment cycles (R-CHOP-21) and CC99282 in combination with R-CHOP-21 in subjects with previously untreated, high risk ...

3. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   ... prednisone or equivalent are permitted;; Adrenal replacement steroid doses including doses > 10 mg daily prednisone are permitted;; A brief (less than 3 weeks) ...

4. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

   Receiving chronic systemic corticosteroid therapy > 20 mg of prednisone daily. Being treated with other anti-cancer therapies (approved or investigational) ...

5. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Patients should be excluded if they have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or ...

6. Ospemifene (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Primidone; Rifabutin; Rifampin; Rifapentine; Secobarbital; St John's Wort; Thiopental. Other Interactions. Certain medicines should not be used at ...

7. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   Chronic obstructive pulmonary disease (COPD) requiring chronic oral steroid therapy of > 10 mg prednisone daily or equivalent at the time of registration.

8. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   Patients should be excluded if they have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or ...

9. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   Hematopoietic cell transplantation (HCT) recipients newly requiring systemic glucocorticoid therapy (at ≥ 1mg/kg/day prednisone or equivalent) for chronic GVHD ...

10. Clinical trials - Oncology (Medical)

    ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...